(Q40745355)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888656%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888656%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888656%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Michael Hitchcock

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888656%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1

Tomas Cihlar

1 reference

8 December 2019

Dale E Greenwalt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888656%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 April 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888656%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888656%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888656%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888656%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

37-45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888656%20AND%20SRC:MED&resulttype=core&format=json

Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Peripheral neuropathy: zalcitabine reassessed

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

A semi-automated neutral red based chemosensitivity assay for drug screening

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Update on highly active antiretroviral therapy: progress and strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

3'-Azido-3'-deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

In vitro potency of inhibition by antiviral drugs of hematopoietic progenitor colony formation correlates with exposure at hemotoxic levels in human immunodeficiency virus-positive humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

In vitro toxicity of 3′‐azido‐3′‐deoxythymidine, carbovir and 2′, 3′‐didehydro‐2′, 3′‐dideoxythymidine to human and murine haematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2',3'-dideoxycytidine (ddC).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Pharmacokinetics of stavudine in patients with AIDS or AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Major O-glycosylated sialoglycoproteins of human hematopoietic cells: differentiation antigens with poorly understood functions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Antiretroviral therapy of HIV-1 infection: established treatment strategies and new therapeutic options

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Experimental studies of the hematologic and immune system toxicity of nucleoside derivatives used against HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Transient alterations in cellular permeability in cultured human proximal tubule cells: implications for transport studies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

The effect of food on pharmacokinetics of zalcitabine in HIV-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Metabolism, mitochondrial uptake and toxicity of 2', 3'-dideoxycytidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

3'-Azidothymidine significantly alters glycosphingolipid synthesis in melanoma cells and decreases the shedding of gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Single-dose pharmacokinetics and safety of abacavir (1592U89), zidovudine, and lamivudine administered alone and in combination in adults with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

3'-Azidothymidine (zidovudine) inhibits glycosylation and dramatically alters glycosphingolipid synthesis in whole cells at clinically relevant concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900210-8

7 January 2021

10.1016/S0166-3542(01)00210-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11888656%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference